Mounjaro and vision side effects: what the clinical evidence shows

What the UK prescribing information and regulatory guidance actually record

Mounjaro's Summary of Product Characteristics, available on the electronic Medicines Compendium, lists blurred vision among known side effects. It is not in the very common or common categories; across the SURMOUNT and SURPASS clinical programmes, involving thousands of adults with obesity and type 2 diabetes, eye-related adverse events were infrequent. That said, infrequent is not the same as impossible, and the regulatory signal exists for a reason.

The MHRA has communicated broadly about GLP-1 receptor agonists and the eyes, particularly in the context of diabetes. When blood glucose levels fall quickly after starting treatment (which tirzepatide can produce, especially in people who also take insulin or a sulfonylurea) the retina can respond in ways that temporarily or, in some cases, more durably affect sight. This is a known mechanism across the entire medicine class, not specific to Mounjaro. People who already have diabetic retinopathy, even mild or well-controlled, need their prescriber to factor that in before treatment begins and to monitor more closely once it has. The NHS tirzepatide medicine page advises telling your doctor immediately if you notice changes to your eyesight.

For people without diabetes, the evidence base for vision effects is thinner, partly because the mechanism is less well understood outside a glucose-change context. Blurred vision reported by non-diabetic participants in trials was generally mild and transient, and often coincided with the gastrointestinal symptoms common in the first weeks of a new dose.

Diabetic retinopathy: why rapid glucose lowering creates a specific risk

This is the area that attracts the most clinical attention. Diabetic retinopathy is damage to the small blood vessels at the back of the eye caused by prolonged high blood sugar. When glucose drops significantly in a short time (as it can with an effective GLP-1 or dual GIP/GLP-1 treatment) the retina can react adversely. Paradoxically, the eye is better adapted to a consistently high glucose environment than to a sudden shift away from it. NICE's appraisal of tirzepatide, TA1026, notes this risk and the importance of clinical assessment before prescribing.

This does not mean tirzepatide cannot be used by people with diabetic retinopathy. It means the decision involves the prescriber weighing the benefits of glucose and weight reduction against the pace at which that change happens, and ensuring ophthalmology follow-up is in place. Some people with pre-existing retinopathy will experience worsening that stabilises once glucose levels settle at their new, lower baseline; in others the picture is more complex. These are conversations to have with your prescriber before starting, not after noticing a problem.

If you are considering treatment, our Mounjaro overview covers the broader eligibility picture, and our prescribers at the nume clinical team discuss diabetes-related eye history as a standard part of the consultation.

When a change in vision on Mounjaro needs medical help today

Most blurred vision early in treatment is benign and temporary, linked to the same gastric-slowing effects that cause some people to feel mildly unwell in the first week of a new dose. It usually improves on its own as the body adjusts. The picture that demands same-day attention is quite different.

Contact your GP, optician, or go directly to A&E if you notice any of the following: sudden loss of vision in one or both eyes, new floaters or flashing lights, distortion of straight lines, eye pain, or any rapid change to your vision that feels out of the ordinary. These could signal retinal events unrelated to tirzepatide, but they need urgent assessment regardless of what you are taking. Tell the clinician you are on Mounjaro and when you last injected.

If you experience these symptoms around the time of a new dose or a dose increase, that timing is worth mentioning, but do not delay seeking care to look up whether it is listed as a side effect. Eyes are not a wait-and-see situation. You can also report any suspected side effects (including vision symptoms) via the MHRA Yellow Card scheme, which helps build the longer-term safety evidence base for newer medicines like Mounjaro.

Our full guide to Mounjaro side effects covers the broader picture, including the GI symptoms that are far more common in the first weeks of treatment.

Questions to raise at your consultation, and why the conversation matters

Eye health does not always make it onto the list of things people think to mention when they are filling in a health questionnaire about weight loss. It should. Tell your prescriber if you have any existing eye condition, if you are under an ophthalmologist, or if you wear glasses or contact lenses for a prescription that has changed noticeably in the last year. These details shape the monitoring plan, not the door you walk through.

For people with type 2 diabetes, make sure your most recent retinal screening result is recorded somewhere you can reference. NHS diabetic eye screening happens annually for most adults with diabetes, and if you are overdue, getting that done before or shortly after starting tirzepatide is sensible practice. Some people going through treatment with us have found that starting in the new year or around a holiday break gives them the time to attend appointments they had been putting off, and our guide to side effects if you are taking Mounjaro explains why the months after starting a new treatment are exactly when follow-up matters most.

If you have questions about your specific history and whether Mounjaro is suitable, our prescribers cover this as part of every consultation, there is no separate charge. It is also worth reading about what happens when people experience no side effects on Mounjaro, as understanding the full range of responses helps set realistic expectations before you begin. You can also browse our FAQs or, if you have a specific concern, reach our team through the contact page. The consultation itself is through our treatment page, where our prescribers are happy to walk through the five Mounjaro side effects most commonly raised by new patients, including how each one tends to present and resolve. You can also find a detailed breakdown of each side effect of Mounjaro if you want to understand the clinical picture in more depth before your appointment.